{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:04:43Z","timestamp":1778684683977,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.vaccine.2016.05.053","type":"journal-article","created":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T21:30:09Z","timestamp":1465421409000},"page":"3913-3919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evaluation of different heterologous prime\u2013boost immunization strategies against Babesia bovis using viral vectored and protein-adjuvant vaccines based on a chimeric multi-antigen"],"prefix":"10.1016","volume":"34","author":[{"given":"Jos\u00e9 Manuel","family":"Jaramillo Ortiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Paula","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Gravisaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina Soledad","family":"Paoletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria Noely","family":"Montenegro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvina Elizabeth","family":"Wilkowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.05.053_b0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.vetpar.2006.01.041","article-title":"Immune control of Babesia bovis infection","volume":"138","author":"Brown","year":"2006","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2016.05.053_b0010","first-page":"116","article-title":"Estimating of direct economic losses caused by the tick Boophilus microplus and associated diseases in Argentina","volume":"23","author":"Sp\u00e4th","year":"1994","journal-title":"Therios"},{"key":"10.1016\/j.vaccine.2016.05.053_b0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0169-4758(99)01471-4","article-title":"Designing blood-stage vaccines against Babesia bovis and B. bigemina","volume":"15","author":"Brown","year":"1999","journal-title":"Parasitol Today (Personal Ed)"},{"key":"10.1016\/j.vaccine.2016.05.053_b0020","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1017\/S0031182014000961","article-title":"Vaccines against bovine babesiosis : where we are now and possible roads ahead","author":"Florin-christensen","year":"2014","journal-title":"Parasitol Today"},{"key":"10.1016\/j.vaccine.2016.05.053_b0025","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.vaccine.2013.05.091","article-title":"Utilizing poxviral vectored vaccines for antibody induction-progress and prospects","volume":"39","author":"Draper","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.05.053_b0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2240","article-title":"Viruses as vaccine vectors for infectious diseases and cancer","volume":"8","author":"Draper","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.05.053_b0035","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3390\/v7041726","article-title":"The evolution of poxvirus vaccines","volume":"7","author":"S\u00e1nchez-Sampedro","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2016.05.053_b0040","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/mt.2012.223","article-title":"ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans","volume":"20","author":"Sheehy","year":"2012","journal-title":"Mol Ther: J Am Soc Gene Ther"},{"key":"10.1016\/j.vaccine.2016.05.053_b0045","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1038\/mt.2011.176","article-title":"Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors","volume":"19","author":"Sheehy","year":"2011","journal-title":"Mol Ther: J Am Soc Gene Ther"},{"key":"10.1016\/j.vaccine.2016.05.053_b0050","doi-asserted-by":"crossref","first-page":"e31208","DOI":"10.1371\/journal.pone.0031208","article-title":"Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors","volume":"7","author":"Sheehy","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2016.05.053_b0055","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jphp.12350","article-title":"Adenoviral vectors as novel vaccines for influenza","volume":"67","author":"Coughlan","year":"2015","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.vaccine.2016.05.053_b0060","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1128\/JVI.02055-12","article-title":"Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors","volume":"87","author":"Tan","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.05.053_b0065","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1128\/JVI.02058-12","article-title":"Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors","volume":"87","author":"Penaloza-MacMaster","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.05.053_b0070","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1099\/0022-1317-81-11-2573","article-title":"Update on adenovirus and its vectors","volume":"81","author":"Russell","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.05.053_b0075","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1016\/j.vaccine.2014.06.075","article-title":"Vaccine strategies against Babesia bovis based on prime-boost immunizations in mice with modified vaccinia Ankara vector and recombinant proteins","volume":"32","author":"Jaramillo Ortiz","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.05.053_b0080","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/1040638711416845","article-title":"An applied printing immunoassay with recombinant Nc-SAG1 for detection of antibodies to Neospora caninum in cattle","volume":"5","author":"Wilkowsky","year":"2011","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.vaccine.2016.05.053_b0085","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.ijpara.2008.03.001","article-title":"Babesiosis: recent insights into an ancient disease","volume":"38","author":"Hunfeld","year":"2008","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2016.05.053_b0090","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0008-8749(91)90257-C","article-title":"IFN-y enhances secretion of IgG2a from IgG2a-committed LPS-stimulated murine 6 cells : implications for the role of IFN-7 in class switching","volume":"104","author":"Bossie","year":"1991","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2016.05.053_b0095","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-3024.1995.tb00880.x","article-title":"Interferon-gamma and the induction of protective IgG2a anti bodies in non-lethal Plasmodium berghei infections of mice","author":"Waki","year":"1995","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2016.05.053_b0100","first-page":"21","article-title":"Immune response in mice that lack the interferon-y receptor","volume":"991","author":"Huang","year":"1991","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2016.05.053_b0105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1128\/IAI.63.1.349-352.1995","article-title":"Immunization of cattle with recombinant babesia bovis merozoite surface antigen-1","volume":"63","author":"Hines","year":"1995","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.05.053_b0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1865-1682.2010.01117.x","article-title":"Immunization of Bos taurus steers with Babesia bovis recombinant antigens MSA-1, MSA-2c and 12D3","volume":"57","author":"Antonio Alvarez","year":"2010","journal-title":"Transboundary Emerging Dis"},{"key":"10.1016\/j.vaccine.2016.05.053_b0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.vetpar.2009.09.023","article-title":"In silico predicted conserved B-cell epitopes in the merozoite surface antigen-2 family of B. bovis are neutralization sensitive","volume":"167","author":"Dominguez","year":"2010","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2016.05.053_b0120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0166-6851(02)00329-8","article-title":"Babesia bovis merozoite surface protein-2c (MSA-2c) contains highly immunogenic, conserved B-cell epitopes that elicit neutralization-sensitive antibodies in cattle","volume":"127","author":"Wilkowsky","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2016.05.053_b0125","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1128\/IAI.70.4.2039-2048.2002","article-title":"Immunodominant epitopes in Babesia bovis rhoptry-associated protein 1 that elicit memory CD4 (+) -T-Lymphocyte responses in B. bovis-immune individuals are located in the amino-terminal domain","volume":"70","author":"Norimine","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.05.053_b0130","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.vaccine.2010.10.041","article-title":"Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates","volume":"29","author":"Capone","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.05.053_b0135","doi-asserted-by":"crossref","first-page":"e115161","DOI":"10.1371\/journal.pone.0115161","article-title":"A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS","volume":"9","author":"De Barra","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2016.05.053_b0140","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1128\/IAI.00315-10","article-title":"New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1","volume":"78","author":"Goodman","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.05.053_b0145","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJMoa0805832","article-title":"Protection against a malaria challenge by sporozoite inoculation","author":"Roestenberg","year":"2009","journal-title":"New Engl J Med Original"},{"key":"10.1016\/j.vaccine.2016.05.053_b0150","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"7","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.vaccine.2016.05.053_b0155","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1128\/IAI.70.9.5304-5306.2002","article-title":"Cellular immunity, but not gamma interferon, is essential for resolution of Babesia microti infection in BALB\/c mice","volume":"70","author":"Clawson","year":"2002","journal-title":"Infect Immun"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2016.05.053_b0160","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0047-6374(83)90036-2","article-title":"The effect of age on the infection and immunoresponsiveness of mice to Babesia microti","volume":"23","author":"Habicht","year":"1983","journal-title":"Mech Ageing Dev"},{"issue":"Suppl 6","key":"10.1016\/j.vaccine.2016.05.053_b0165","doi-asserted-by":"crossref","first-page":"G29","DOI":"10.1016\/j.vaccine.2008.09.070","article-title":"Vaccination of cattle against B. bovis infection with live attenuated parasites and non-viable immunogens","volume":"26","author":"Fish","year":"2008","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16303796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16303796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T22:16:18Z","timestamp":1600726578000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16303796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":33,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0264410X16303796"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.05.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of different heterologous prime\u2013boost immunization strategies against Babesia bovis using viral vectored and protein-adjuvant vaccines based on a chimeric multi-antigen","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.vaccine.2016.05.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}